A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Conditions

Hyperphosphatemia Patients on Hemodialysis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Taisho selected site, Tokyo, Japan
Contact: Study coordinator (Taisho Director) · shu_chiken@taisho.co.jp · 81-3-3985-1118

Study leads

Taisho Director
Study Director
Taisho Pharmaceutical Co., Ltd.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

Hyperphosphatemia Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Tokyo, Japan

A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Tokyo, Japan

Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia

Hyperphosphatemia

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Guangzhou, China